WebbAssociate Director at Shape Therapeutics Inc. Seattle, Washington, United States. 704 ... Last week’s AAV #genetherapy formulation landscape 💊 … WebbAdeno-associated virus (AAV) vectors have become an important tool for delivering therapeutic genes for a wide range of neurological diseases. AAV serotypes possess …
Thomas Packard - Associate Director - Shape …
WebbWe deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. Shape TX … Webb11 jan. 2024 · Shape TX gene therapy platform comprises RNAskip™, RNAfix™, and RNAswitch™ payload technology, next-generation tissue-specific AAVid™ delivery … dallas factory death attorney
Roche, Shape team up to advance AAV-based gene therapies …
Webb28 maj 2024 · SEATTLE, May 28, 2024 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable ... Webb3 dec. 2024 · Shape Therapeutics, Inc. (ShapeTX), a next-generation gene therapy company with an industry-leading RNA targeting technology platform, announces today … Webbför 9 timmar sedan · Pear Therapeutics (NASDAQ: PEAR) stock is falling on Friday after the company’s recent bankruptcy filing continues to weigh on its shares. Pear Therapeutics announced its bankruptcy filing while ... dallas factory death lawyer